Navigation Links
Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial
Date:11/1/2007

- HGS expects to have all Phase 3 data available by spring 2009 to support the filing of global marketing authorization applications by fall 2009 -

ROCKVILLE, Md., Nov. 1 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has completed enrollment and initial dosing ahead of schedule in ACHIEVE 2/3, the second of two pivotal global Phase 3 trials of Albuferon(R) (albinterferon alfa-2b) in combination with ribavirin in treatment-naive patients with chronic hepatitis C. ACHIEVE 2/3 is being conducted in patients with genotypes 2 and 3 chronic hepatitis C.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

"We are ahead of our original schedule with both Phase 3 trials of Albuferon and we expect the filing of global marketing applications by fall 2009," said H. Thomas Watkins, President and Chief Executive Officer, HGS. "If the results of our Phase 2 trials are confirmed in Phase 3, we believe Albuferon could become the interferon of choice for the treatment of chronic hepatitis C.

ACHIEVE 2/3 enrolled 933 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C. ACHIEVE 1, the first of the two Phase 3 trials, completed enrollment of 1331 treatment-naive patients with genotype 1 chronic hepatitis C in August 2007. HGS originally projected enrollment of the Phase 3 trials by the end of 2007. Albuferon is being developed by HGS and Novartis under an exclusive worldwide co-development and commercialization agreement entered into in 2006.

"Albuferon requires half as many injections as the long-acting interferons that are currently in use," said David Nel
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... on venture capital investing in Wisconsin has some business ... more private equity financing for its emerging companies. An ... be the State of Wisconsin Investment Board. , ,The ... which is the ninth largest public pension fund in ...
... of every online business. A good partner makes going online ... you time, money, and customers. , ,An important part of ... the company that provides you with the server space, database ... the world. , , Location, location, location ,From ...
... is about more than just doing the usual lessons ... technology is a medium that opens up whole new ... and what the relationship should be between teachers, students ... at MIT Media Lab and co-director of the Lab's ...
Cached Biology Technology:State investment board keeps an eye on Wisconsin's tech trends 2State investment board keeps an eye on Wisconsin's tech trends 3Silent partners: Selecting a web hosting company 2Silent partners: Selecting a web hosting company 3Silent partners: Selecting a web hosting company 4Schrage: Don't think of distance learning as just automation 2Schrage: Don't think of distance learning as just automation 3
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has ... in India 2015-2019" report to their offering. ... this market is the adoption of multimodal biometric ... characteristic of an individual for verification and identification ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
(Date:12/5/2014)... 2014  Tute Genomics, a leader in cloud-based solutions ... A1 funding led by UK-based Eurovestech. Peak Ventures and ... investment round. "We are at a pivotal ... sequencing and seeks new approaches for the diagnosis, treatment ... MD MBA, and CEO of Tute Genomics. "One of ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... protein discovered by Temple University researchers, may also ... in treating leukemia, according to a study by ... Inhibitor, Angiocidin, Induces Differentiation of Monocytes to Macropahges," ... of the journal Cancer Research ( ...
... is known about the world,s largest living turtle, the leatherback. ... hard shell, the behavior and habitats of this critically endangered ... Biology , marine biologist Barbara Block and colleagues give us ... turtles, behavior, in doing so, providing methods that could be ...
... The forests of the future may need to be managed ... any other goal, researchers say in a new federal report ... fix" to the insatiable, often conflicting demands for this precious ... say, as both urban and agricultural demands for water continue ...
Cached Biology News:Tumor-inhibiting protein could be effective in treating leukemia 2Leatherback turtles go with the flow 2New report: Greatest value of forests is sustainable water supply 2New report: Greatest value of forests is sustainable water supply 3
... profiling allows a high-throuput screening of a ... or artifitially induced changes in the expression ... can be detected, studied, classified and compared ... of genes at a glance. Automatized scanning ...
... SYBR Green II RNA gel stain ... stain that has bright fluorescence when bound ... making it ideal for use with either ... or standard UV transilluminators. A 500 µL ...
Rabbit polyclonal to Esa1 ( Abpromise for all tested applications)....
... Green II RNA gel stain is a ... fluorescence when bound to RNA and low background ... either formaldehyde/agarose or polyacrylamide gels using laser scanners ... minigels. A 500 µL unit size (S-7564) and ...
Biology Products: